FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled

The global tinea pedis treatment market is projected to grow at a steady CAGR and surpass US$ 1.7 Bn in revenues by 2027. A new research study titled “Tinea Pedis Treatment Market: Vesicular Tinea Pedis

VRX's Return On Assets of 3.44% is amongst the best returns of the industry. VRX outperforms 87% of its industry peers. The industry average Return On Assets is -40.17%. VRX's Profit Margin of 15.36% is